Ahold Delhaize share buyback update
Apr 17, 2018 06:01 am UTC| Business
Zaandam, the Netherlands, April 17, 2018 - Ahold Delhaize has repurchased 774,934 of Ahold Delhaize common shares in the period from April 9, 2018 up to and including April 13, 2018. The shares were repurchased at an...
China Unicom Teams with Cisco to Enable Cloud + Network Synergy with Segment Routing
Apr 17, 2018 06:00 am UTC| Business
BEIJING, April 17, 2018 -- Recently, China United Network Communications Group Co., Ltd. (China Unicom) officially announced seven new products: Cloud Network Connection, Cloud Networking, Cloud VPV, Cloud Broadband,...
Posting of UK Annual Report and Accounts & Notice of AGM
Apr 17, 2018 06:00 am UTC| Business
NEW YORK, April 17, 2018 -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that its 2017 UK Annual Report and Accounts...
International network of law firms innovating with HighQ
Apr 17, 2018 06:00 am UTC| Business
LONDON, April 17, 2018 -- HighQ is pleased to announce that Ius Laboris, the leading international HR law Alliance, has adopted HighQ’s technology to enhance the value-adding services its member firms around the world...
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Apr 17, 2018 05:16 am UTC| Business
Basel, Switzerland, April 17, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into a license agreement with ArQule, Inc. (NASDAQ: ARQL) for its oncology drug candidate ARQ 087...
Apr 17, 2018 05:01 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 17 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
INNATE PHARMA : AACR 2018, New preclinical data further support ongoing programs
Apr 17, 2018 05:01 am UTC| Business
new preclinical data further support ongoing programs and highlight next generation of immunotherapies Next generation of immunotherapies presented by Chief Scientific Officer Eric Vivier in a meet-the-expert...